Results

Total Results: 1,277 records

Showing results for "death".

121. DEcIDE 33: Summary Variables in Observational Resesarch: Propensity Scores and Disease Risk Scores (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
     May 01, 2012 - Antipsychotic Use and Risk of Sudden Cardiac Death by Cardiovascular Risk Score .................. … Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001;58:1161-67. 24. … Antipsychotic use and risk of sudden cardiac death by cardiovascular risk score Cardiovascular Disease … Antipsychotics and the risk of sudden cardiac death. … Cyclic antidepressants and the risk of sudden cardiac death.

122. Heart-Failure-Natriuretic-Peptide Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_executive.pdf
     November 01, 2013 - The other mortality outcomes (i.e., cardiac and sudden cardiac death) demonstrated less convincing … Sudden cardiac death had increasing HRs across the quintiles of NT-proBNP and an adjusted HR = 1.9 ( … Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated … Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. … N-terminal pro- B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular

123. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - Six months of combination therapy reduced clinical failure, biochemical failure, or death from any … the two, or orchiectomy with diabetes, coronary heart disease, myocardial infarction, sudden cardiac … death, or stroke. … associated with increased risk of diabetes, coronary heart disease, myocardial infarction, sudden cardiac … death, and stroke.

124. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - Six months of combination therapy reduced clinical failure, biochemical failure, or death from any … the two, or orchiectomy with diabetes, coronary heart disease, myocardial infarction, sudden cardiac … death, or stroke. … associated with increased risk of diabetes, coronary heart disease, myocardial infarction, sudden cardiac … death, and stroke.

125. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
     January 24, 2022 - proxy for severe, and ICU admission as a proxy for critical COVID-19 (Table 1 footnotes) COVID-19 death … was defined per WHO classification as "a death resulting from a clinically compatible illness, in a … probable or confirmed COVID-19 case, unless there is a clear alternative cause of death that cannot be … against any reinfection, symptomatic reinfection, and against COVID-19 related hospitalization and death … ; reported as adjusted [a]HR) Nyberg 2022 Comparative analysis of the risks of hospitalisation and death

126. Quitting Smoking | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/quitting-smoking
     February 25, 2014 - Quitting Smoking Description Tobacco use is the most common preventable cause of death

127. Eating Disorders | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/eating-disorders
     March 16, 2017 - Eating disorders can lead to heart and kidney problems and even death.

128. Renal-Artery-Stenosis Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_surveillance.pdf
     June 01, 2012 - In Revascularization + medical therapy versus medical therapy, the HR for death was 0.90 with 95% CI … The HR for overall death was 0.99 with 95% CI= 0.30, 3.24 b. … The HR for Primary end point or death was 0.81 with 95% CI= 0.42, 1.56 8 1 Signal 3. … medical therapy Death: HR= 0.90; 95% CI= 0.69, 1.18; p = 0.46 1 Signal Medical vs. … In other words the reduction in the risk of death has moved from 30% to 10%.

129. Our topic of nomination is Postpartum Hemorrhage. The following is a list of clinical questions practitioners consider when managing such cases: • What should be considered in the initial evaluation of a patient with excessive bleeding in… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/our-topic-of-nomination-is-postpartum-hemorrhage-the-following-is-a-list-of-clinical-questions-practitioners-consider-when-managing-such-cases-what-should-be-considered-in-the-initial-evaluation-of-a-patient-with-excessive-b
     November 01, 2017 - Severe bleeding is the single most significant cause of maternal death worldwide. … In addition to death, serious morbidity may follow postpartum hemorrhage.

130. QUESTIONS What are the appropriate indications for tonsillectomy Recurrent infections how many Sleep disordered breathingShould clinicians administer or prescribe perioperative antibiotics to children undergoing tonsillectomyRELEVANT… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/questions-what-are-the-appropriate-indications-for-tonsillectomy-recurrent-infections-how-many-sleep-disordered-breathingshould-clinicians-administer-or-prescribe-perioperative-antibiotics-to-children-undergoing-tonsillectom
     November 01, 2017 - current estimates of tonsillectomy mortality but a prospective audit reported only 1 postoperative death … electrolyte imbalance or anesthetic complications.1626 Similarly airway compromise is the major cause of death

131. Opioid Abuse and Addiction | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/opioid-abuse-and-addiction
     April 01, 2021 - is also a medicine called naloxone which can reverse the effects of an opioid overdose and prevent death

132. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_executive.pdf
     September 01, 2011 - : Key Question 1: improve neonatal health outcomes, including bronchopulmonary dysplasia, neonatal death … , death within initial hospitalization, significant intraventricular hemorrhage (grade III/IV), necrotizing … , death within initial hospitalization, and maternal withdrawal due to adverse effects (Withdrawal-AE … the strength of evidence favoring the SQ terbutaline pump compared with oral tocolytics for neonatal death … Infant mortality statistics from the 2006 period linked birth/infant death data set.

133. Effective Health Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0136_07-21-2009.pdf
     January 01, 2009 - including sexual function), and patient satisfaction; for surgical procedures, risk of complication and death

134. Willis_respondent_DuBenske_4 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/web-based_willis_respondent.pdf
     January 01, 2009 - • Death  panel  versus  informed  decision-­‐making   o No  one  wants  to  die  

135. CER 5 Renal Artery Stenosis NSD SJ Clean (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_overview.pdf
     June 24, 2014 - respect to the rate of the composite primary end point or any of its individual components, including death

136. RENAL MASS AND LOCALIZED RENAL CANCER *the following questions are recommended to address the healthcare tests and/or treatments this program should consider: • What indicators can be used to predict malignancy and/or aggressiveness of… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/renal-mass-and-localized-renal-cancer-the-following-questions-are-recommended-to-address-the-healthcare-tests-andor-treatments-this-program-should-consider-what-indicators-can-be-used-to-predict-malignancy-andor-aggressivene
     November 01, 2017 - What is the role of competing risks of death, related to age and medical-co-morbidities, in managing … Approximately 30% of tumors recur and 20% of adult instances of renal cancer result in death. … blood transfusion Respiratory complications Cardiovascular complications Venous thromboembolism Death

137. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
     December 11, 2012 - patients with UA/NSTEMI involve the elimination of ischemia and the prevention of adverse events (death … For the majority of patients who are at higher risk of recurrent ischemia, MI, or death, an early invasive … or MI.8-11 For the minority of patients at low or intermediate risk of recurrent ischemia, MI, or death … All-cause death 10 2. Cardiovascular disease-related death 3. Nonfatal MI 4. … o Cardiovascular-related death o Nonfatal myocardial infarction o Revascularization o Stroke o

138. Expanded Guidance on Selected Quantitative Synthesis Topics | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/quantitative-synthesis-expanded-methods/methods
     December 01, 2019 - For example, “cardiovascular event (yes/no)” could be defined as a composite of MI, stroke, and death … Indeed, death was the most important component in 83 percent of trials. … Death and MI together accounted for 6 events in the placebo arm and 5 in the intervention arm. … Thus, despite the composite outcome definition’s inclusion of death and MI, the trial provided little … The combined NNT to prevent one death was 20 over 5 years.

139. The Role of Immunotherapy in the Treatment of Asthma--Evidence Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-196-evidence-summary-immunotherapy-asthma.pdf
     March 01, 2018 - There was insufficient evidence to draw conclusions regarding the effect of SCIT on anaphylaxis or death … • Serious adverse events such as anaphylaxis and death were not reported in the included studies in … non-RCT20 1 case series21 1 case report22 N=792 55 cases Likely (Likelihood of causality) Death … case reports41-43 2 Certain 1 Likely (Likelihood of causality) Unable to draw conclusions Death … low, 1 medium, 1 high) Consistent Direct Precise Undetected SLIT does not increase the risk of death

140. Research Protocol: Breast Reconstruction After Mastectomy: Appendix A (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/breast-reconstruction-mastectomy-protocol-appendix-a.pdf
     June 16, 2020 - or injurious or serious or fatal) AND (effect* or reaction* or event* or outcome* or incident*)) OR death